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Guaianolides constitute a large and diverse group of biolo-
gically active sesquiterpenes. Guaianolide and seco-guaian-
olides can also be used as, for example, scaffolds for the de-
velopment of new active molecules that are readily access-
ible by synthetic methods. Nevertheless, these lactones often
have complex structures that make their synthesis difficult.
The aim of this microreview is to provide an overview of the
developments in guaianolide synthesis by the two major syn-
Introduction
Sesquiterpene lactones (SLs) are amongst the most abun-
dant natural products. More than 8000 structures have been
reported, and they have broad structural and functional di-
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thetic strategies: semi-synthesis and total synthesis. Partial
and total syntheses of guaianolides are described, with par-
ticular emphasis placed on the methods reported in the last
decade. The methods discussed include rearrangements, cy-
cloadditions, ring-closing metathesis, the use of transition-
metal catalysts, photochemical reactions, and other recently
developed techniques as key steps.
versity.[1] SLs have been isolated and identified from numer-
ous species of higher and lower plants, chiefly from species
of Compositae. These compounds are primarily classified
on the basis of their carbocyclic skeletons into pseudo-
guaianolides, guaianolides (including seco-guaianolides),
germanocranolides, eudesmanolides, heliangolides, and
hyptocretenolides, with guaianolides being the most com-
mon.
Guaianolides are based on a 5,7,5-ring system that exists
in two main forms: the guaian-6,12-olide and the guaian-
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8,12-olide structures. The seco-guaianolides have the least
common skeleton of the guaianolides, with a C–C single
bond broken in one of the rings (Figure 1). Plants that con-
tain such compounds as the active principles have been used
in traditional medicine throughout history for the treatment
of many diseases.[2] Therefore, it is not surprising that these
compounds display an extensive range of biological activi-
ties, such as anti-inflammatory, antimicrobial, antiviral, and
anti-feedant properties, cytotoxicity against tumor cell lines,
fungicidal activity and potential allelopathy among others
(Figure 2). Several synthetic strategies have been designed
for these compounds because in most cases only small
quantities can be isolated from natural sources.
Figure 1. Guaianolide skeletons.
Figure 2. Structural diversity of guaianolides and their importance
as bioactive molecules.
Many guaianolides and seco-guaianolides contain an α-
methylene butyrolactone system, a privileged moiety that is
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present in 10% of all natural products.[3] It is well known
that the alkylating properties, and hence the potential
tumor-inhibiting abilities, of these sesquiterpene γ-lactones
arise from Michael-type interaction between the α,β-unsat-
urated exomethylene lactone moiety and the nucleophilic
cellular components. Extensive research has been carried
out to characterize the molecular mechanisms of the anti-
cancer activities of these compounds and their potential use
as chemopreventive and chemotherapeutic agents. Both the
cytotoxicity and the anti-inflammatory properties of SLs
are mediated by the α,β-unsaturated carbonyl functions,
such as cyclopentenone and the α-methylene γ-lactone moi-
ety. The former unit seems to be slightly more associated
with cytotoxicity, whereas the latter is believed to be the
major group that mediates the anti-inflammatory activity
of SLs.[4] The bioactivity has also been attributed to other
factors, such as the lipophilicity of a molecule and its geom-
etry.[5]
These natural products provide a rich source of biolo-
gically validated small-molecule scaffolds that fit the phi-
losophy of biology-oriented synthesis. Indeed, guaianolides
can serve as excellent leads for drug development and have
been synthetic targets for more than four decades. Never-
theless, molecular complexity can pose formidable synthetic
challenges. Numerous methodologies have been described,
and these can be classified into two main groups: total syn-
thesis in cases in which the construction of the guaianolide
skeleton involves the use of readily available small mol-
ecules as starting materials, and hemi-synthesis or semi-syn-
thesis when the strategy involves a structurally complex
molecule or an isolated natural compound, usually a eudes-
mane or germacrane sesquiterpene.
Sesquiterpene lactones and guaianolides have been ex-
tensively reviewed in the literature.[1,6,7,8] The aim of this
microreview is to provide the interested reader with a sum-
mary of the most relevant synthetic strategies and an up-
date of the latest developments in the synthesis of these fun-
damental compounds.
Semi-Synthesis
Semi-synthesis is usually used when the precursor mol-
ecule is structurally too complex or too costly, or if its pro-
duction by total synthesis is too inefficient in terms of yield.
In guaianolide chemistry, the use of some eudesmane or
guaiane sesquiterpenoids has always been a common ap-
proach (Figure 3). The ubiquitous nature and the structural
simplicity of these systems are thought to be very closely
related. The majority of the strategies involve isomerization
Figure 3. Sesquiterpenoid skeletons.
Trends in the Synthesis and Functionalization of Guaianolides
(including photoisomerization), solvolysis, or rearrange-
ment of the sesquiterpenoid to obtain the desired skeleton.
It is also common practice to functionalize a readily avail-
able skeleton to generate new products.
Despite the developments in total synthesis, semi-synthe-
sis is still a useful tool and is sometimes more effective for
obtaining a prodrug with promising biological activity, es-
pecially if the starting materials are readily available. In the
following sections the key and latest strategies are discussed
according to the type of skeleton used as the starting mate-
rial.
Guaianolide Strategies
The simplest strategy starts with a molecule that already
contains the guaianolide skeleton, which is modified to ob-
tain the desired products.
Dehydrocostuslactone (DHC, 3, Figure 2), first synthe-
sized by Rigby et al. in 1984,[9] has been used as a starting
material because it is readily available from crude costus
resin oil (Saussurea lappa) by column chromatography
(CC). The use of DHC for the generation of synthetic
guaianolide-type derivatives and the biological activities of
the resulting compounds have been reported. In particular,
in 1984 Kalsi et al.[10] used DHC and isozaluzanin C to syn-
thesize twenty new derivatives each with an exocyclic meth-
ylene group at C-4 conjugated with a C-3 ketone. These
compounds were tested as plant growth regulators.
A DHC derivative named subexpinnatin, previously iso-
lated by Massanet and co-workers in 1982,[11] was used by
the same group in 1987 after saponification in a regio- and
stereoselective chemical transformation to yield the natural
oxetane lactone subexpinnatin C (13).[12] This transforma-
tion involves a photocycloaddition reaction between the α-
methylene γ-lactone 9 and acetaldehyde as a new method
to obtain the oxetane ring (Scheme 1). Five years later the
same group reported the synthesis of natural SLs soulangi-
anolide A,melampomagnolides AandB,zaluzanin Candiso-
zaluzanin C from DHC, costunolide, and parthenolide by
use of SeO2 and tBuOOH.[13]
In 2000, Macías et al. completed an intensive structure–
activity study directed towards evaluating the effects of fif-
teen guaianolide derivatives obtained from DHC (3) on the
Scheme 1. Synthesis of oxetane lactone subexpinnatin C.
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growth and germination of several mono- and dycotyledon
target species (Figure 4, Table 1).[13,14]
Figure 4. Guaianolides tested (see also Table 1).
Table 1. Guaianolides tested by Macías et al.
R1 R2 R3 R4 R5 R6 R7
a H H H OH H –CH2–
b H H OH H H –CH2–
c H H H H OH –CH2–
d H H H OH OH –CH2–
e H OH H OH OH –CH2–
f OH H H OH OH –CH2–
g H H –O– H –CH2–
h H H H H H CH2O H
i H H H H H H CH2O
j H H H H H CH2O OH
k H H H OH H H CH2O
l H H H OH OH H CH2O
m H H H H OH H CH2O
n H H H OH OH H CH3
o H OH H OH OH H CH3
In 2013, Chen and co-workers[15] reported the applica-
tion of the Heck reaction in the synthesis of guaianolide
sesquiterpene lactone derivatives that selectively inhibited
resistant acute leukemic cells. Under standard Heck reac-
tion conditions, a series of SLs were obtained from DHC
(3) and micheliolide (15) after arylation of the α-methylene-
γ-lactone moiety (Scheme 2). In the case of micheleolide it
was essential to protect the hydroxy group at the C-3 posi-
tion.
Grossheimin, cynaropicrin, arglabin, estafiatin, ludartin,
achillin, grossmisin, and artefin are other guaianolide lact-
ones that have been widely functionalized to obtain a series
of structural derivatives of both chemical and biological
interest. Several derivatives of these lactones have been re-
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Scheme 2. Application of Heck reactions in the synthesis of guaianolides.
ported in the last decade by Raldugin, Adekenov, and co-
workers.[16] All of these methodologies led to new structures
that were usually established by X-ray crystal analyses.
Among them it is important to note the generation of
chloro derivatives of grossmisin and achillin by treatment
with chlorine, of dinitro derivatives of achillin and
grossmisin from a one-step synthesis with gaseous NOCl,
of dialkyl phosphonate derivatives of arglabin and grosshei-
min by use of sodium dimethyl and diethyl phosphonates,
of a pentachloro derivative and a new dichlorocarbene de-
rivative from arglabin and estafiatin obtained in the pres-
ence of a crown ether, and of halohydrins of ludartin by use
of LiCl in the presence of CH3CO2H (Figure 5).
Figure 5. Some of the guaianolide derivatives obtained by Adek-
enov and co-workers.
Furthermore, in 1989 Barbetti and co-workers synthe-
sized a sequence of 13-phenylseleno derivatives of guaianol-
ides from grossheimin (27) and cynaropicrin (28); these
compounds showed cytotoxic activity against κB cell cul-
tures.[17] In 2012 Csuk et al. synthesized several derivatives
of arglabin obtained by extraction, including modifications
on the endocyclic double bond. Arborescin (30) was gener-
ated from arglabin (2) by hydrogenation.[18] Bhat et al. also
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obtained amino analogues of ludartin (31), a potent and
selective cytotoxic agent,[19] by use of a Michael addition at
the exocyclic double bond of the α-methylene γ-lactone as
a key step (Scheme 3).
Scheme 3. Synthesis of guaianolide derivatives.
Less common guaianolides have been used in the synthe-
sis of several derivatives with fascinating structural diver-
sity. In 1972 Shafizadeh and Bhadane synthesized vis-
cidulin B from the known guaianolide cumambrin B, pre-
viously isolated from Artemisia nova Nels.[20] In 1992 Gior-
dano and co-workers reported the reduction and acetyl-
ation of dehydroleucodin, helenalin, hymetin, mexicanin I,
Trends in the Synthesis and Functionalization of Guaianolides
and ludartin guaiane lactones as part of a structure–activity
relationship study on the gastric cytoprotective effect of sev-
eral guaianolides.[21] In 2005 Bruno et al. identified activity
against tumor cell replication in several synthetic guaianol-
ide derivatives of repsin.[22]
Germacranolide Strategies
Germacranolides, biogenetic precursors of guaianolides,
have frequently been used as starting materials in their syn-
thesis.
In 1980 González et al. carried out a biomimetic cycliza-
tion of gallicin, isolated from Artemisia maritima gallica ssp.
Willd, to yield guaianolides.[23] In 1988 the same group pre-
pared melampomagnolide B (34, Scheme 4) and its 11,13-
dihydro derivative from parthenolide (33) by allylic oxid-
ation with SeO2/HOOtBu, followed by NaBH4 reduction
and then conversion into guaianolides through biomimetic
cyclization.[24] Melampomagnolide B and its 11,13-dihydro
derivative were converted to epimeric trans-guaianolides 35
by acid treatment. The same group also reported the biomi-
metic synthesis of 5α-hydroxyguaianolides from vulgarin.[25]
In 1989 Bordoloi and co-workers described the reaction of
tagitinin C, isolated from Tithonia diversifolia, with SnCl2
to produce cyclotagitinin C, a guaianolide that can be bio-
mimetically transformed into pseudoguaianolides.[26]
Scheme 4. Germacranolide strategies based on 33.
In 1993 Fischer et al. reported the biomimetic transfor-
mation of parthenolide (33), isolated from Magnolia
grandiflora L., by use of BF3-mediated rearrangement to
yield guaianolides and seco-guaianolides, such as micheliol-
ide (15, Scheme 4).[27] In an extension of the work of Fi-
scher et al., in 2012 Chen, Gao, and co-workers generated a
series of guaianolides by use of parthenolide as the starting
material. These guaianolides are particularly interesting be-
cause they can selectively eradicate acute myelogenous leu-
kemia (AML) stems or progenitor cells.[28]
In 2008, Massanet and co-workers reported the synthesis
of some guaianolides and germacranolides from costunol-
ide (36), which is readily available from the roots of Sauss-
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urea lappa.[29] This study demonstrated that conformational
changes in the structures of germacranolides can be in-
duced by placing an oxygenated functionality at carbon C-
6 with the appropriate orientation. The methodology de-
scribed is suitable for the preparation of eudesmanolides
and guaianolides found in umbelliferous plants (Scheme 5).
Scheme 5. Germacranolide strategies based on 36.
Eudesmanolide Strategies
(–)-α-Santonin (38, Scheme 6) is the most important and
widely used compound for the synthesis of guaianolides.
Compound 38 is an abundant eudesmanolide that has been
isolated from the genus Artemisia (especially from Artemi-
sia maritime, A. cina, or A. chamaemelifolia). Santonin ex-
ists as colorless flat prisms that turn pale yellow due to the
action of light. 8α-Hydroxysantonin, named artemisin, is
also found in these plants, although it is less abundant.[30]
(–)-α-Santonin is also commercially available and can be
readily functionalized. This eudesmanolide lactone contains
an A-ring with a cross-conjugated dienone system and a
lactone moiety, which makes it very interesting as a starting
material for the synthesis of a variety of compounds with
promising biological importance, especially those with eu-
desmane, guaiane, and elemane skeletons.[26]
The transformation of santonin (38) into guaianolides
has been carried out by two different methods: the photo-
chemical rearrangement of the dienone system present in
the A-ring of santonin and the solvolytic rearrangement of
an appropriate 1-sulfonate derivative (Scheme 6). Irradia-
tion of santonin with UV light in AcOH solution is a pho-
tochemical process that has been known since 1957 to pro-
vide guaianolides such as O-acetylisophotosantonic lactone
(40).[31] This transformation is the initial step in several re-
cent syntheses of guaianolides and related compounds and
has been described as a single-crystal-to-single-crystal reac-
tion.[32]
O-Acetylisophotosantonic lactone (40) was used by
Marx and White in 1969 for the synthesis of achillin (46)
after epimerization at C-1.[33] In 1976 Winter and Lindauer
also used this compound in the synthesis of photunolide
(50) in order to corroborate the structure and stereochemis-
try of the product obtained by photoisomerization of the
germacranolide dihydrocostunolide, which proceeded with
a high degree of regio- and stereoselectivity (Scheme 7).[34]
In addition, in 1986 Sharma and co-workers described the
biomimetic transformation of isophotosantonic lactone
into pseudoguaianolides.[35]
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Scheme 6. Transformation of α-santonin into guaianolides.
Scheme 7. Syntheses of achillin and photunolide.
Scheme 8. Synthesis of (–)-estafiatin.
In 1979 Greene, Crabbé, and co-workers reported the
stereoselective synthesis of (–)-estafiatin (53) from α-santo-
nin (38).[36] The key intermediate in the synthesis was the
trisubstituted olefin, which was obtained as a mixture of
tri- and disubstituted olefins by high-temperature de-
hydration in hexamethylphosphoric triamide, with the mix-
ture separated on silver-nitrate-impregnated silica gel
(Scheme 8).
Ando et al. described a significant synthetic study in
which several natural sesquiterpene guaianolides or deriva-
tives were obtained by use of α-santonin as the starting ma-
terial.[37] It is important to mention the syntheses of arbo-
rescin (30), 1,10-epi-arborescin, and the trisubstituted olefin
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that served as the key intermediate in Greene and Crabbé’s
synthesis of estafiatin. This route included as a key step the
solvolytic rearrangement of a mesyloxy-eudesmano lact-
one.[38] This methodology was also applied in the synthesis
of zaluzanins C and D, 3-epi-zaluzanin C, Mokko lactone,
DHC, eremathin, ludartin, leucodin, kaunolide, arborescin,
and other related compounds (Scheme 9).
A similar synthetic strategy was presented by Pedro and
co-workers for the stereoselective synthesis of 4α-hydroxy-
8,12-guaianolides, 3-oxa-guaianolides, and dihydroestafia-
tin, dihydroludartin, (–)-compressanolide, and dihydromi-
cheliolide.[39] This approach was also used by Barbosa et al.
in the synthesis of new α-santonin derivatives.[40]
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Scheme 9. Key step in the synthesis of guaianolides.
Scheme 10. Synthesis of (+)-absinthin.
An efficient methodology was reported by Zhai and co-
workers in 2004 for the synthesis of (+)-absinthin (58) from
α-santonin (38) in ten steps.[41] (+)-Absinthin was isolated
in 1953 by Herout as the main dimeric guaianolide from
wormwood Artemisia absinthium L.[42] The first step of the
synthetic strategy was the generation of O-acetylisophoto-
santonin (40), which after nine steps yielded the desired nat-
ural product in 19 % overall yield (Scheme 10).
In 2012 Lei et al. described the first biomimetic synthesis
of (–)-gochnatiolides A–C and (–)-ainsliadimer B, based on
their proposed biogenetic pathway.[43] The main features of
the synthesis are one-pot cascade transformations including
Saegusa oxidation, intermolecular Diels–Alder cycload-
dition, and radical-mediated allylic oxidation, which allow
the rapid generation of products in a collective manner. A
biomimetic transformation from gochnatiolide B (61) to
ainsliadimer B (62) was achieved through a direct enone hy-
dration. Dehydrozaluzanin C (59), prepared in 11 steps
from α-santonin, was used as a common precursor
(Scheme 11). In 2013 Qin and co-workers also reported the
synthesis of ainsliadimer B and gochnatiolides A and B.[44]
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The key step in the route was a cross-Diels–Alder cycload-
dition of a modified dehydrozaluzanin C that allowed the
highly regio- and stereoselective assembly of the skeletons.
In the last decade, seco-guaianolides have attracted a
great deal of attention in the continued search for bioactive
compounds that can act as leads for drug discovery or as
tools for biological studies. In 2009 Hay, Westwood, and
co-workers reported the isolation, synthesis, and biological
evaluation of iso-seco-tanapartholides 68 and 69.[45] A key
step was the late-stage oxidative cleavage reaction, which
was carried out in the absence of protecting groups to give
the natural products directly (Scheme 12). The study also
showed that the synthetic derivatives of the seco-guaianol-
ides were indeed inhibitors of the NF-κB signaling pathway.
In 2012 Macías et al. described a facile procedure for the
preparation of bioactive seco-guaianolide and of other
guaianolides.[46] There are two key steps in this interesting
synthetic strategy. A high-yielding photochemical reaction,
optimized through an extensive study of the reaction condi-
tions, revealed that isophotosantonin (39) can be obtained
as the main product and in high yields by judicious choice
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Scheme 11. Syntheses of (–)-gochnatiolides A–C and (–)-ainsliadimer B.
Scheme 12. Synthesis of iso-seco-tanapatholides.
Scheme 13. Synthesis of seco-guaianolide and of other guaianol-
ides.
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of conditions. Furthermore, oxidation with ozone to cleave
the C=C bond to give ketones provided the highly oxygen-
ated and active seco-guaianolide 70 (Scheme 13).
Total Synthesis
Interest in hydroazulenic lactones (5,7-ring) has in-
creased steadily over the past four decades, given the useful
properties of these compounds. Although several synthetic
strategies have been proposed, only a very few have been
successful for the synthesis of pseudoguaianolides, particu-
larly ()-damsin (71), ()-confertin (72), ()-ambrosin
(73), ()-psilostachyin C (74), and ()-aromatin (75, Fig-
ure 6).[47] Several methodologies have been developed and
these can be separated according to the proposed synthetic
strategy. A summary of these strategies and recent methods
is provided below.
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Figure 6. Early pseudoguaianolide target compounds.
Hydroazulene Strategies by Ring Enlargement or
Rearrangement
The use of rearrangement reactions aside, most of the
synthetic strategies for such hydroazulenes (also named bi-
cyclo[5.3.0]decanes) start with a five-membered ring com-
pound, and the seven-membered ring is elaborated by ring
enlargement or isomerization reactions[48] followed by lact-
one ring formation.
The 1983 publications by Vandewalle et al. (described in
the next section)[49] largely concern the first total synthesis
of the guaianolides ()-compressanolide and ()-estafiatin.
Nevertheless, to the best of our knowledge, the first synthe-
sis of the 4,5-epoxyosmitopsin family, starting from cyclo-
hexane-1,3-dione, was reported in 1980 by Posner. This was
the first, highly stereocontrolled, total synthesis of an α-
methylene-substituted guaianolide, although it is not a nat-
ural product (Scheme 14).[50] In this synthesis two of the six
chiral centers were introduced stereoselectively and the
other four were introduced with virtually complete
Scheme 14. Synthesis of the 4,5-epoxyosmitopsin family.
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stereocontrol. This methodology starts with a Michael ad-
dition of cyclohexane-1,3-dione (76) to methyl vinyl ketone,
followed directly by sodium borohydride reduction to ob-
tain a cyclic enol ether. The octalone 81 was subsequently
obtained as a precursor of hydroazulenone, which itself
would be an intermediate for the preparation of epoxyguai-
anolide 85.
Rigby et al. reported the total synthesis of two guaianol-
ides – ()-dehydrocostuslactone (3) and ()-estafiatin
(53) – and later of ()-grosshemin (27).[51,9] The methodol-
ogy used the cis-fused hydroazulenic intermediates derived
from tropone 86 through “conjugate” 1,8-addition of the
Grignard reagent derived from 2-(2-bromoethyl)-1,3-diox-
olane through an unusual Lewis acid olefin cyclization. The
()-dehydrocostuslactone was synthesized in twelve steps,
and ()-estafiatin was obtained in two more steps
(Scheme 15). ()-Grosshemin was synthesized three years
later by a similar methodology.[52]
An interesting and convenient methodology reported by
Lee in 1997 includes a radical cyclization to achieve the
total synthesis of (+)-cladantholide (102) and (–)-estafiatin
(53).[53] Starting from commercially available (R)-(–)-car-
vone (94), the highly substituted cyclopentane 97
(Scheme 16) was prepared in a four-step sequence[54] based
on epoxidation of the enone, regioselective epoxide open-
ing, and a Favorskii rearrangement that resulted in ring
contraction to a cyclopentanecarboxylate. This is an excel-
lent strategy that leads to the cyclopentanecarboxylate 97,
which can be modified and used as a precursor in numerous
reactions. The bromoacetal 95 was obtained in three further
steps, and this was subjected to standard high-dilution radi-
cal-generating conditions with AIBN/Bu3SnH to give the
hydroazulenic acetal. The final keto-lactone was prepared
by radical cyclization through THP removal and Jones
oxidation.
In a huge synthetic study, Ley et al. developed the total
synthesis of several members of the thapsigargin family and
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Scheme 15. Synthesis of ()-dehydrocostuslactone and ()-estafiatin.
Scheme 16. Synthesis of (+)-cladantholide and (–)-estafiatin.
achieved the first absolute stereochemical assignment of
thapsivillosin C.[55] These prodrug derivatives showed selec-
tive in vivo cytotoxicity against prostate tumors, as well as
many other promising activities such as potent histamine
liberation and selective and irreversible inhibition of the
ubiquitous sarco-endoplasmic reticulum Ca2+ ATP-de-
pendent pumps (SERCAs) up to subnanomolar concentra-
tions.[55a] The synthetic plan was reported in different publi-
cations, in which some potential routes to prepare the guai-
anolide skeleton were presented along with the iterations
that led to the best strategy. The benefits of this approach
are the inherent substrate control that governs each newly
established stereogenic center. This allowed the generation
www.eurjoc.org © 2015 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim Eur. J. Org. Chem. 2015, 2093–21102102
of thapsigargin (1, Figure 1) as a single diastereoisomer in
42 synthetic steps from (S)-carvone (94, average yield of
89 % per step).
A concise summary of the strategy used by Ley and co-
workers shows a striking similarity between the initial steps
and the work reported by Lee et al. (Scheme 17).
Continuing towards the synthesis of thapsigargin, Mas-
sanet et al. developed the enantioselective synthesis of 7,11-
dihydroxyguaianolide 124 with the desired stereochemis-
try.[56] Their methodology had two key steps: photochemi-
cal rearrangement of the eudesmane-like γ,δ-unsaturated
ketone 121 to give the corresponding guaiane from (+)-di-
hydrocarvone and the regioselective oxidation of the unpro-
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Scheme 17. Synthesis of thapsigargin.
tected tetrahydroxylated ketone 123 to yield the dihydroxy
lactone with the required stereochemistry (Scheme 18). Re-
cently, the same group developed KMnO4-promoted α-
acyloxylation of cyclic enones with linear carboxylic acids.
Scheme 18. Synthesis of 7,11-dihydroxyguaianolides.
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This methodology has been applied to the synthesis of
densely oxygenated guaianolides (Scheme 19).[57]
Several other interesting approaches have also been re-
ported. Kozikowski et al. described a method for the syn-
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Scheme 19. Scope of the α-acyloxylation reaction with guaiane
scaffolds.
thesis of the hydroazulenic ring system by an intramolecular
nitrile oxide cycloaddition reaction that involved treatment
of 3-chlorocyclopent-1-ene with the sodium salt of dimethyl
malonate to achieve the coupling.[58] A similar approach
was used by Tanis et al. for the synthesis of bicyclo[5.3.0]
decane in five steps and in 36% overall yield by furan-ter-
minated cationic cyclization.[59] In 1990 Monde developed
an innovative synthesis of lettucenin A, a guaianolide phy-
toalexin isolated by the same group from lettuce inoculated
with the bacterium Pseudomonas cichorii.[60] This synthesis
starts with para-cresol to obtain indanone, and the skeleton
of the product was subsequently generated by reductive ring
expansion of a dibromomethyl-substituted cyclohexadien-
one.
In recent years some new strategies that avail themselves
of recent advances in organic synthesis have been reported.
A promising synthetic route to guaianolides, based on a
Scheme 20. Approach to guaianolides by the MARDi cascade.
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new multicomponent reaction sequence (MARDi cascade),
was presented by Coquerel and Rodriguez et al.. A highly
chemoselective domino transformation was subsequently
used for the expeditious stereoselective preparation of the
tricyclic core.[61] The MARDi cascade with the β-oxo ester
129 and the crotonaldehyde 130 yielded the cycloheptanol
135 as a single isomer. In the multicomponent reaction
(MCR) recently developed by the same group, a Michael-
initiated sequence can be used as an approach to guaianol-
ides because it allows diastereoselective access to a variety
of carbo- and heterocyclic seven-membered rings under
convenient and environmentally friendly conditions
(Scheme 20).[62] The key factor in the synthetic application
of the MARDi cascade to target-oriented synthesis is the
chemo-differentiation of the two carboxylate groups in the
products. The reaction allows the control of up to five
newly created stereocenters and complete chiral induction
in the case of an optically active ketone precursor. The high
level of diastereoselectivity observed has been attributed to
the overall thermodynamic control of the reaction.
A diastereoselective route to the 5,7,5-tricyclic guaianol-
ide core was presented by Donaldson and co-workers in
2009.[63] This route is based on the Cope rearrangement of
divinylcyclopropane 142, which was prepared by alkenyl
Grignard exo-addition to a (1-methoxycarbonylpen-
tadienyl)Fe(CO)3+, followed by oxidative decomplexation.
An additional key reaction involves oxidative rearrange-
ment of a 3,4-epoxy-1,7-diol to generate a γ-lactone
(Scheme 21).
An interesting variant of the strategy previously reported
by Lee et al. and Ley et al.[55c] for the synthesis of the guai-
anolide ring system was described by Maier in 2010; it
started from (R)-(–)-carvone (94) to afford the diazoketone
149 in 13 steps.[64] A bimolecular carbonyl ylide–alkyne cy-
cloaddition reaction was followed by 1,3-cycloaddition of
the cyclic carbonyl ylide with a trans-annulated cyclo-
pentane ring to generate an oxygen-bridged polycycle
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Scheme 21. Approach to guaianolides based on the Cope re-
arrangement.
stereoselectively through a Rh2(OAc)4-catalyzed reaction
from the diazoketone precursor with trapping by allyl pro-
piolate. A Curtius degradation led to transformation of the
cycloadduct into the guaianolide skeleton (Scheme 22).
Scheme 22. Synthesis of the guaianolide ring system.
In 2010 Avery et al. designed and developed the synthesis
of new guaianolide endoperoxides such as 155 as potential
antimalarial agents.[65] These SLs, which are named tha-
peroxides, were prepared as precursors during the synthesis
of thapsigargin, and the compounds have striking structural
similarities with artemisinin and thapsigargin (1). An analo-
gous methodology was used to obtain the cyclopentane-
carboxylate 151 from (S)-carvone (94),[54] and this was
transformed into a bis-olefin precursor in four steps. The
proposed ring-closing metathesis of the previously obtained
precursor cleanly generated the bicyclic intermediate in the
presence of the second-generation Grubbs catalyst in high
yield. Dess–Martin periodinane oxidation of C6-OH was
followed by C-7 homologation by selective kinetic enoliz-
ation, with ethyl pyruvate as the electrophile, to give the
bicyclic ketone 153, which in three steps gave the key inter-
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mediate for a stereoselective [4+2] cycloaddition of singlet
oxygen and introduction of the endoperoxide (Scheme 23).
Scheme 23. Synthesis of guaianolide endoperoxide 155.
Hydroazulene-Lactone Strategies Involving Intramolecular
Cycloaddition
Related strategies start with the formation of the lactone
ring, with the hydroazulene backbone subsequently ob-
tained by intramolecular cycloaddition.
An innovative strategy for the enantioselective synthesis
of (+)-arglabin (2) was presented by Reiser et al. in 2007.[66]
This promising natural product, isolated from Artemisia
glabella, has been successfully used in Kazakhstan for the
treatment of breast, colon, ovarian, and lung cancers.[16h]
The synthetic strategy is an extension of the work pre-
viously reported by the same group for the enantioselective
synthesis of trans-4,5-disubstituted γ-butyrolactones such
as 160,[67] in which allylation of cyclopropane with the allyl-
silane led to the first key intermediate. A second Sakurai
allylation with 2-methylallylsilane and subsequent ring-clos-
ing metathesis in the presence of the second-generation
Grubbs (G-II) catalyst gave the desired guaiane skeleton
162 (Scheme 24). The synthesis of (+)-arglabin (2) was com-
pleted in further steps, which included removal of the hy-
droxy group by the Barton–McCombie protocol and α-
methylenation.
In the same year Xu and co-workers completed the first
total synthesis of ent-8-epi-grosheimin 168 in an approach
based entirely on substrate-controlled methods.[68] The
strategy featured the formation of the C-ring before ad-
dressing the construction of the B-ring from cyclopentyl
carbaldehyde 164, obtained by a procedure similar to that
described by Lee et al.[53] The key steps were a stereoselec-
tive Mukaiyama aldol addition, an oxidative γ-lactoni-
zation, and an intramolecular aldehyde–ene cyclization
(Scheme 25).
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Scheme 24. Synthesis of (+)-arglabin.
Scheme 25. Synthesis of ent-8-epi-grosheimin.
Recently a powerful synthesis of highly oxygenated 6,12-
guaianolide analogues was described by Brummond and
co-workers.[69] The scope of the tandem allylboration/lact-
onization chemistry established by Hall[70] was expanded
to provide functionalized allene-yne-containing α-methyl-
ene butyrolactone 173, which underwent a RhI-catalyzed
cyclocarbonylation reaction to afford the 5,7,5-ring system
174. In a previous report,[69a] the benefits of the early-stage
incorporation of an α-methylene butyrolactone for the RhI-
catalyzed allenic Pauson–Khand reaction (APKR) were
demonstrated.
The methodology starts with allenyl ester 169, obtained
from a monoprotected butynediol through a Johnson–
Claisen rearrangement. Ester 169 reacted with methoxy-
methylamine hydrochloride and isopropylmagnesium chlor-
ide to afford the corresponding Weinreb amide, which was
converted into alkynone 170 by treatment with ethynylmag-
nesium bromide. Reduction of the carbonyl group of the
ynone with lithium aluminum hydride, direct conversion
into the corresponding methyl ether, deprotonation of the
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terminus of the alkyne with nBuLi, and addition of methyl
chloroformate gave the alkynoate 171. Treatment of 171
with DIBAL, CuI, MeLi, and ClCH2BPin gave allyl-
boronates in a Z/E ratio of 1.2:1. These compounds were
not separated, and the mixture was subjected to an allylbor-
ation/lactonization step by heating with 3-phenylpropiolal-
dehyde to obtain a complex mixture. Treatment of this com-
plex mixture with PTSA produced lactone trans-173 as a
2:1 mixture of diastereoisomers, and subsequent treatment
with rhodium biscarbonyl chloride dimer and removal of
the TBDPS group yielded the cyclocarbonylation product
as a mixture of diastereoisomers (Scheme 26).
Scheme 26. Synthesis of 6,12-guaianolide analogues.
A very recent strategy was presented by Winne et al.,[71]
who assembled the guaianolide ring system in three
straightforward synthetic operations by using a highly dia-
stereoselective intramolecular [4+3] cycloaddition reaction
Trends in the Synthesis and Functionalization of Guaianolides
of a catalytically generated furfuryl cation intermediate.
The first precursor was generated in two steps by treating
the anion derived from furan β-keto ester 176 with bromo-
diene 175. Reduction of the resulting alkylated product with
sodium borohydride gave the corresponding diastereomeric
β-hydroxy esters. After persistent investigation. and in se-
arch of a more “natural” guaianolide ring system, the sec-
ond precursor was treated with catalytic amounts of galli-
um(III) triflate, a highly reactive Lewis acid, to give a rather
clean conversion to 6,12-furanoguaine cycloadducts 177
and 178 (Scheme 27).
Scheme 27. Three-step synthesis of the guaianolide ring system.
Hydroazulene Strategies Based on Intermolecular
Cycloaddition
Hydroazulenes can also be obtained by stereocontrolled
cycloaddition of two precursors followed by some modifica-
tions.
As mentioned above, Vandewalle et al. achieved the total
synthesis of the guaianolides ()-compressanolide (189)
and ()-estafiatin (53) in 1983.[49] A general and efficient
route to the functionalized guaiane skeleton previously hav-
ing been reported, ()-compressanolide was obtained from
Scheme 28. Synthesis of ()-compressanolide and ()-estafiatin.
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the perhydroazulenic lactone 188 in five steps. This lactone
had previously been obtained in nine steps by starting from
cyclopent-2-enone (179) and generating the diketone ()-
183.[72] ()-Estafiatin was obtained from the lactone inter-
mediate 190 in six steps including an epimerization. A sum-
mary of the total synthesis in which non-naturally occur-
ring guaianolides have been described is shown in
Scheme 28 and this involves the rearrangement of a func-
tionalized intermediate 182.
The methodology outlined above includes a [2+2] photo-
cycloaddition between 1,2-bis(trimethylsilyloxy)cyclo-
pentene (180) and cyclopent-2-enone (179), followed by nu-
cleophilic addition to the ketone and an α-diol oxidative
cleavage of the resulting triol to yield the perhydroazulene-
dione 183, which provided access to the two desired prod-
ucts.
In 1992, Jacobi et al. presented a new synthetic approach
involving a Diels–Alder/retro Diels–Alder transformation
of an acetylenic oxazole to synthesize ()-geigerin (196,
Scheme 29).[73] Geigerin was isolated in 1936 from Geigeria
aspera Harv., a south African species.[74]
In 2003[75] Deprés et al. reported a versatile synthetic ap-
proach in which they found that 7-methylcycloheptatriene,
obtained from the commercially available tropyllium cation
(191) in 43% overall yield, underwent a regio- and stereose-
lective cycloaddition and a dichloroketene ring expansion/
elimination sequence of the [2+2] cycloadduct with diazo-
methane to give hydroazulenone 193. The same hydro-
zulenone was used years later as an intermediate in the total
synthesis of ()-geigerin (196, Scheme 29).[76] A similar
strategy was reported by the same group in the total
synthesis of Δ-11,13-didehydroguaianes and -guaianolides
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Scheme 29. Synthesis of ()-geigerin.
such as ()-achalensolide and ()-pechueloic acid in
2009.[77]
Several approaches involving [2+2] cycloadditions have
also been reported to generate guaianolides and pseudo-
guaianolides. For example, Schore reported the synthesis of
11-oxatricyclo[5.3.1.0]undecane derivatives through the
Co2-(CO)8-catalyzed cyclization of alkenes with various
8-oxabicyclo[3.2.1]oct-6-ene derivatives.[78] Lange et al.
achieved the synthesis of four sesquiterpene lactones from
the photoadduct previously prepared by [2+2] cycload-
dition between cyclobutene-1-carboxylic acid and the dia-
stereomeric enone with use of a 350 nm irradiation
source.[79]
Conclusions
Natural products such as guaianolides and their deriva-
tives have for decades served as an important class of tar-
gets, in large measure because of their demonstrated effi-
cacy as bioactive agents. These compounds provide inspira-
tion for the development of new chemistry, as well as al-
lowing the use of newly developed synthetic capabilities to
define the necessary methodologies.
As highlighted above, the synthesis of guaianolides has
always been a challenge, due to the structural diversity of
these compounds. Numerous methodologies have been de-
scribed, and these have encompassed a tremendous variety
of synthetic strategies. The approaches can be classified into
two main groups: semi-synthesis and total synthesis.
In semi-synthesis most of the stereogenic centers are al-
ready preformed; santonin has proven to be a practical
starting material thanks to the improvement in the high-
yielding photochemical reaction to obtain the guaianolide
skeleton. This key step has been reported for the synthesis
of promising products such as seco-guaianolides and di-
meric guaianolides.[41,43b,46]
The total synthesis approach involves the generation of
stereocenters by diastereoselective cycloadditions. Other
useful synthetic methodologies such as MARDi cascade,
transition-metal catalysis, or ring-closing metathesis have
also been introduced.[66,61,80] In recently reported strategies
www.eurjoc.org © 2015 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim Eur. J. Org. Chem. 2015, 2093–21102108
the aim has been to obtain guaianolides in high yields in
the fewest possible steps.[71]
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